Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetrodotoxin-resistant (TTX-r) neuronal voltage-gated sodium channels, primarily comprising the Nav1.8 (SCN10A) and Nav1.9 (SCN11A) isoforms, are specialized ion channels essential for the transmission of pain signals in the peripheral nervous system [nih.gov, guidetopharmacology.org]. Unlike most other sodium channels, these isoforms are relatively insensitive to the pufferfish toxin tetrodotoxin and are almost exclusively expressed in the small-diameter sensory neurons of the dorsal root ganglia [wikipedia.org, nih.gov]. Nav1.8 plays a dominant role in the upstroke of action potentials in nociceptors, especially during cold or inflammatory conditions, while Nav1.9 contributes to setting the resting membrane potential and the threshold for firing [nih.gov, frontiersin.org]. Because of their restricted peripheral expression, these channels are highly attractive therapeutic targets for treating chronic, inflammatory, and neuropathic pain without the central nervous system side effects associated with opioids, such as addiction or respiratory depression [vrtx.com, nih.gov]. Recent clinical success has been achieved with suzetrigine (VX-548), a first-in-class selective Nav1.8 inhibitor that utilizes an allosteric mechanism to stabilize the channel in its closed state [vrtx.com, researchgate.net].
Selective inhibition of sodium ion conductance through the channel pore or allosteric stabilization of the inactivated/closed state, thereby reducing the excitability of nociceptive neurons and preventing the transmission of pain signals to the central nervous system [vrtx.com, nih.gov].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetrodotoxin-resistant neuronal voltage-gated sodium channel (TTX-r Nav).